A 6 Month Safety Study Of Ciclesonide Nasal Aerosol (Zetonna®) And Ciclesonide Nasal Spray (Omnaris®) In Subjects 12 Years And Older With Perennial Allergic Rhinitis (PAR)

Clinical trial NCT01654536 · COMPLETED

Trial details

NCT number: NCT01654536
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Perennial Allergic Rhinitis

Start date: 2012-09-01
Primary completion: 2013-07-01
Enrollment: 737

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.